Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001144204-19-007520
Filing Date
2019-02-14
Accepted
2019-02-14 06:10:30
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A tv513409_sc13ga.htm SC 13G/A 43972
2 GRAPHIC image_001.jpg GRAPHIC 2418
  Complete submission text file 0001144204-19-007520.txt   49175
Mailing Address 68 CUMBERLAND STREET, SUITE 301 WOONSOCKET RI 02865
Business Address 68 CUMBERLAND STREET, SUITE 301 WOONSOCKET RI 02865 (401)762-0045
MultiCell Technologies, Inc. (Subject) CIK: 0000811779 (see all company filings)

EIN.: 521412493 | State of Incorp.: DE | Fiscal Year End: 1130
Type: SC 13G/A | Act: 34 | File No.: 005-39597 | Film No.: 19600409
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1799 UNION STREET, 3RD FL SAN FRANCISCO CA 94123
Business Address 10100 SANTA MONICA BLVD., STE. 2200 LOS ANGELES CA 90067-4164
LA JOLLA COVE INVESTORS INC (Filed by) CIK: 0001123220 (see all company filings)

EIN.: 000000000 | State of Incorp.: CA
Type: SC 13G/A